Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.

Literature DB >> 19798057

Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.

Christoph Lahtz, René Stranzenbach, Eckhard Fiedler, Peter Helmbold, Reinhard H Dammann.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2009 PMID： 19798057 DOI： 10.1038/jid.2009.226

Source DB: PubMed Journal: J Invest Dermatol ISSN： 0022-202X Impact factor: 8.551

Keyword Cloud
Cited

× No keyword cloud information.

31 in total

Review 1. Genetic alterations of PTEN in human melanoma.

Authors: Almass-Houd Aguissa-Touré; Gang Li
Journal: Cell Mol Life Sci Date: 2011-11-11 Impact factor: 9.261

Review 2. Driver mutations in melanoma: lessons learned from bench-to-bedside studies.

Authors: Janice M Mehnert; Harriet M Kluger
Journal: Curr Oncol Rep Date: 2012-10 Impact factor: 5.075

3. Constitutional promoter methylation and risk of familial melanoma.

Authors: Paula L Hyland; Laura S Burke; Ruth M Pfeiffer; Melissa Rotunno; David Sun; Prasad Patil; Xiaolin Wu; Margaret A Tucker; Alisa M Goldstein; Xiaohong Rose Yang
Journal: Epigenetics Date: 2014-02-13 Impact factor: 4.528

Review 4. Epigenetic markers in melanoma.

Authors: Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal: Melanoma Manag Date: 2015-11-24

10. The antiproliferative response of indole-3-carbinol in human melanoma cells is triggered by an interaction with NEDD4-1 and disruption of wild-type PTEN degradation.

Authors: Ida Aronchik; Aishwarya Kundu; Jeanne G Quirit; Gary L Firestone
Journal: Mol Cancer Res Date: 2014-07-09 Impact factor: 5.852

Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.

Review 1. Genetic alterations of PTEN in human melanoma.

Review 2. Driver mutations in melanoma: lessons learned from bench-to-bedside studies.

3. Constitutional promoter methylation and risk of familial melanoma.

Review 4. Epigenetic markers in melanoma.

Review 5. Targeting the PI3K pathway for cancer therapy.

Review 6. Genetics and epigenetics of the skin meet deep sequence.

7. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

8. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Review 9. Revisiting determinants of prognosis in cutaneous melanoma.

10. The antiproliferative response of indole-3-carbinol in human melanoma cells is triggered by an interaction with NEDD4-1 and disruption of wild-type PTEN degradation.